Glasgow's worldwide status in the field of medical research is getting stronger by the minute and, thanks to a new agreement contract, the only way is up.
The ongoing united approach between NHS Greater Glasgow and the city's three universities (Glasgow, Strathclyde and Caledonian) has achieved so much that Professor Sir John Arbuthnott has signed an agreement to set this partnership in stone.
The health service Chairman sealed the ‘University/NHS Partnership Agreement' to ensure that the existing working relationship between everyone from university lab researchers to GPs, makes further healthcare advances in our city.
So what has the joint way of working achieved so far?
Professor Ian Greer, Deputy Dean of the Medical Faculty at Glasgow University, gave the example of how 4,250 Glasgow women took part in the partnership's research into how certain pregnancy complications may cause vascular problems in later life.
He said: "Key research like this is constantly undertaken by lab staff in our hospitals and researchers at the universities. It lets us use patients to learn about health issues, make new discoveries and formulate treatment for the future."
In short, the university and health service melting point has everything from strong intellectual capability to direct links with what's going on with the public at health centres – key ingredients for healthcare advances.
Professor Chris Packard, a Research and Development Lead Officer for NHS Greater Glasgow, added: "Other areas our partnership working has seen developments in are ultrasound scanning, cholesterol medication, anaesthetics and arthritis drugs.
"Glasgow is a relatively small city, but our unique way of working and the amazing skill and dedication of the staff involved mean we have an exciting medical future to look forward to, and the new Partnership Agreement will guarantee that."
Professor Sir John Arbuthnott agreed, saying: "Glasgow and the West of Scotland has an international reputation as a world leader in research, particularly in the fields of cardiovascular disease, cancer, medical neuroscience and inflammation.
"This partnership agreement is great news as it will allow us to further develop our work in attracting and undertaking groundbreaking research, bringing benefit not only to the patients in Glasgow but to people from across the globe."
For media enquiries, contact:
Caroline Jarvie on 0141 201 4447